In July 2018, the Pennsylvania Supreme Court announced its decision to review a ruling by the Pennsylvania Court of Common Pleas regarding the statute of limitations in a case regarding the drug Risperdal. Essentially, the Supreme Court will have to decide whether the Court of Common Pleas was correct in dismissing the Plaintiffs’ case on summary … [Read more...]
Johnson & Johnson’s Action Spikes Risperdal Cases Filed in PA Court
Risperdal lawsuits are highly sensitive because the plaintiffs involved here are psychologically compromised young boys. Risperdal (risperidone) is an antipsychotic medication that is believed to have caused mental and physical trauma and torture to young boys who grew breasts (gynecomastia), many of those who chose to a surgical remedy to … [Read more...]
Risperdal Infographic
Risperdal is a drug manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It was developed and originally approved in 1993 to be used as an antipsychotic medication. However, soon after receiving its original FDA-approval, Janssen began to market Risperdal to those who were not originally intended to take the drug; … [Read more...]
More Risperdal Cases Going to Trial
Pharmaceutical giant Johnson & Johnson has been bleeding out money in the last three years litigating and settling claims made against it in regards to Risperdal. The antipsychotic drug is responsible for triggering disfiguring gynecomastia (breast development) in young boys. Risperdal is a prescription antipsychotic drug that is often … [Read more...]
Recent Victories for Risperdal Victims Should Encourage More to Take Action
After several recent verdicts against Risperdal maker Johnson & Johnson (J&J), the future looks very promising for the roughly 1,600 cases that are still pending against the company in Philadelphia. In February, 2015, a jury handed a verdict to a plaintiff who suffered Risperdal injuries. Two more victories followed before the end of the … [Read more...]
Recent Comments